Table 2 Association between clinicopathological factors and Fibronectin and p53 IHC scores in OCCCa/OHGSeCa
Fibronectin IHCscore | p53 IHCscore | |||||||
|---|---|---|---|---|---|---|---|---|
High (≧3) | Low (3<) | p-value | High (≧6) | Low (6<) | p-value | |||
n | n (%) | n (%) | n (%) | n (%) | ||||
Age | <58 | 61 | 14 (23.0) | 47 (77.0) | 0.7 | 23 (37.7) | 38 (62.3) | 0.6 |
(years) | ≧58 | 66 | 12 (18.2) | 54 (81.8) | 29 (44.0) | 37 (56.0) | ||
Clinical | I | 40 | 7 (17.5) | 33 (82.5) | 0.7 | 4 (10.0) | 36 (90.0) | < 0.0001 |
FIGO stage | II / III / IV | 87 | 19 (21.8) | 68 (78.2) | 48 (55.2) | 39 (44.8) | ||
Histology | OCCCa | 69 | 20 (29.0) | 49 (71.0) | 0.01 | 6 (8.7) | 63 (91.3) | < 0.0001 |
OHGSeCa | 58 | 6 (10.3) | 52 (89.7) | 46 (79.3) | 12 (20.7) | |||
Tumor size | <11.2 | 82 | 11 (13.4) | 71 (86.6) | 0.01 | 41 (50.0) | 41 (50.0) | 0.008 |
(cm) | ≧11.2 | 45 | 15 (33.3) | 30 (66.7) | 11 (24.4) | 34 (75.6) | ||
LN | Positive | 27 | 11 (40.7) | 16 (59.3) | 0.008 | 15 (55.6) | 12 (44.4) | 0.1 |
metastasis | Negative | 100 | 15 (15.0) | 85 (85.0) | 37 (37.0) | 63 (63.0) | ||
Distant | Positive | 12 | 4 (33.3) | 8 (66.7) | 0.4 | 10 (83.3) | 2 (16.7) | 0.004 |
metastasis | Negative | 115 | 22 (19.1) | 93 (66.7) | 42 (36.5) | 73 (63.5) | ||